VALID TRIAL
Both CHIA and your personal trial have the following criteria:
╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╤═════════╕
│ Personal Criteria                                  │ CHIA Criteria                                      │   Score │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╪═════════╡
│ Scheduled for bilateral varus rotational osteotomy │ Scheduled for bilateral varus rotational osteotomy │     100 │
│ (VRO) with or without associated soft tissue and   │ (VRO) with or without associated soft tissue and   │         │
│ osseous procedures                                 │ osseous procedures                                 │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Preoperative use of an anticoagulant (Plavix,      │ Preoperative use of an anticoagulant (Plavix,      │     100 │
│ warfarin, lovenox, etc.)                           │ warfarin, lovenox, etc.)                           │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ History of hypersensitivity to EACA                │ History of hypersensitivity to EACA                │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ History of thromboembolic event (e.g., PE or DVT)  │ History of thromboembolic event (e.g., PE or DVT)  │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ History of renal insufficiency or failure          │ History of renal insufficiency or failure          │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Use of hormone replacement therapy or hormonal     │ Use of hormone replacement therapy or hormonal     │     100 │
│ contraceptive agents within days prior to surgery  │ contraceptive agents within days prior to surgery  │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Use of acetylsalicylic acid (ASA), antiplatelet    │ Use of acetylsalicylic acid (ASA), antiplatelet    │     100 │
│ agents within 7 days prior to surgery              │ agents within 7 days prior to surgery              │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Pregnant                                           │ Pregnant                                           │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Breastfeeding                                      │ Breastfeeding                                      │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Not received neuraxial anesthesia                  │ Not received neuraxial anesthesia                  │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Congenital or acquired coagulopathy as evidence by │ Congenital or acquired coagulopathy as evidence by │      99 │
│ INR \>1.4 or PTT \> 1.4 times normal, or Platelets │ INR >1.4 or PTT > 1.4 times normal, or Platelets   │         │
│ \<150,000/mm3 on preoperative laboratory testing   │ <150,000/mm3 on preoperative laboratory testing    │         │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╧═════════╛

Only your personal trial has the following criteria:
╒═══════════════════════════════════╤═══════════════════════════════════════════╤═════════╕
│ Personal Criteria                 │ CHIA Criteria                             │   Score │
╞═══════════════════════════════════╪═══════════════════════════════════════════╪═════════╡
│ Must have minimum age of 1 Year   │ History of renal insufficiency or failure │      39 │
├───────────────────────────────────┼───────────────────────────────────────────┼─────────┤
│ Must have maximum age of 18 Years │ Not received neuraxial anesthesia         │      39 │
╘═══════════════════════════════════╧═══════════════════════════════════════════╧═════════╛

CHIA has no unique criteria

Levenshtein Ratio of Entire trial at once: 95
Average Levenshtein Ratio of individual lines: 90.53846153846153
OverAll Ratio: 92.76923076923077
